Division of Biology and Medicine
BioMed Research Administration

COVID-19 Resources

Resources and guidance for research related to the COVID-19 pandemic.

COVID-19 (Novel Coronavirus): Resources Relating to Research

COGR (Council on Governmental Relations) COVID-19 Resources

Federal Agency Guidance

National Institutes of Health (NIH)

Guidance

Proposal Submission & Award Management
Human Subjects & Clinical Trials
Peer Review 
FAQs
Resources

Funding Opportunities Specific to COVID-19:

  • NOT-AI-20-034 (3/25/20) Notice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (Applications will be accepted on a rolling basis from March 25, 2020 to February 5, 2021)
  • NOT-GM-20-025 (3/25/20) Urgent Competitive Revisions to NIGMS Grants to Address the Coronavirus Pandemic (Applications will be accepted on a rolling basis from March 25, 2020 to February 5, 2021)
  • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional),PA-20-135 (3/10/20) (Please check with each ICs contact person listed on the announcement to know what areas will be of interest for each participating NIH IC)

National Science Foundation (NSF)

Guidance: 

SAMHSA

Office of Naval Research (ONR)

Office of Naval Research (ONR) Frequently Asked Questions (FAQs) For Current and Prospective Awardees Impacted by Novel COVID-19 (3/27/20)

HRSA

DARPA

Department of Defense (DOD)

COVID-19 Frequently Asked Questions